FDA Clearance Tracker · P170029-S004
CALCIVIS Imaging System
Last checked: Nov 20, 2026Latest source record: Mar 3, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 3, 2025
Approved
Time to decision
90 days
Received Dec 3, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P170029-S004
- Device name
- CALCIVIS Imaging System
- Applicant
- Calcivis Limited
- Applicant location
- Edinburgh
- Received
- Dec 3, 2024
- Decided
- Mar 3, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170029
Device type
- Device class
- Class III
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
approval for the manufacturing scale up of the drug product (photoprotein) for use in the CALCIVIS Imaging System
Source documents
Other decisions for Calcivis Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CALCIVIS Imaging SystemPMA supplement
P170029-S003 · Decided Oct 13, 2023 · 31 days after receipt · Panel Track
Device type: Caries detection product with drug or biologic (QJX) · Dentistry & Oral Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.